The Molecular Imaging Market was valued at USD 8.92 billion in 2024 and is projected to reach USD 9.32 billion in 2025 and USD 13.97 billion by 2034, advancing at a CAGR of 4.6% during the forecast period 2025–2034. Key players include Bruker, Canon Medical Systems Corporation, Cubresa Inc., GE HealthCare, Koninklijke Philips N.V., Mediso Ltd., Positron, Shimadzu Corporation, Siemens Healthineers AG, and United Imaging Healthcare Co., Ltd. This article examines application, demographic, and end-use trends relevant to procurement and product strategy.

Cardiovascular Applications Expected to Grow

The cardiovascular segment is expected to witness significant growth during the forecast period, owing to the rising global burden of heart-related disease and the need for early, accurate diagnosis. According to the American Heart Association, heart disease in the US is expected to affect at least 60% of adults by 2050.

Molecular imaging allows doctors to assess blood flow, detect heart damage, and evaluate treatment effectiveness at the molecular level. As awareness of heart health grows and new imaging agents are developed, providers are turning more often to molecular imaging for cardiovascular care. The application segmentation also covers neurology, oncology, respiratory, and gastrointestinal uses.

Growing Geriatric Population Expands the Patient Base

The world's population is aging. According to Eurostat, the number of people aged 65 and above was 449.3 million in 2024. A growing geriatric population faces a higher likelihood of conditions such as Alzheimer's disease, cancer, and heart problems, all of which require advanced tools for monitoring and treatment planning. As the geriatric population expands, demand for healthcare services that include molecular imaging increases.

Hospitals Dominate End Use

Among end users, which include hospitals, diagnostic imaging centers, and research institutes, the hospital segment dominated in 2024. Hospitals offer widely available advanced equipment and skilled professionals, and they serve as primary points of diagnosis and treatment for cancer, heart disease, and neurological disorders. Their ability to invest in high-end equipment and integrate imaging into patient care workflows gives hospitals a strong advantage in the Molecular Imaging Market.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/molecular-imaging-market

PET/CT and Theranostics: Industry Developments

Leading suppliers are expanding capabilities in PET/CT and related platforms. In June 2024, Siemens Healthineers received FDA clearance for its Biograph Trinion PET/CT scanner, designed for oncology, cardiology, theranostics, and neurology with AI-driven workflow and low operating costs. Siemens Healthineers also offers PET/CT and PET/MRI systems supporting disease detection, therapy planning, and theranostics.

In December 2024, GE HealthCare acquired Nihon Medi-Physics to expand radiopharmaceutical development for neurology, cardiology, oncology, and theranostics, and in June 2025 it unveiled molecular imaging technologies at SNMMI 2025 to enable earlier detection of cardiac conditions.

Regional Dynamics

North America held the largest share in 2024, driven by healthcare infrastructure and investment in medical technology. Asia Pacific is expected to record the highest CAGR on rising healthcare awareness, expanding infrastructure, and growing cancer and cardiovascular caseloads. Japan's universal health insurance system covers 30% of medical expenses, while India's rapidly developing healthcare sector is adopting advanced imaging in urban diagnostic centers. High initial cost remains a restraint.

Segmentation and Competitive Landscape

The Molecular Imaging Market is segmented by modality into molecular ultrasound imaging, PET, SPECT, NMR spectrometers, and others. Leading global corporations dominate through extensive research and development, and they pursue mergers, acquisitions, partnerships, and collaborations to enhance offerings and expand into new regions, while newer companies introduce innovative products to meet end-user demand.

Siemens Healthineers operates in more than 70 countries and employs approximately 72,000 people, and Philips offers computed tomography systems with AI-enabled tools and advanced imaging software designed to improve diagnostic accuracy and workflow efficiency.

Hospitals, diagnostic imaging centers, and research institutes form the end-use landscape, and the report covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to record the highest CAGR, helped by government support for healthcare modernization and research that is introducing advanced imaging technologies. In India, rapid healthcare sector development and an increasing burden of cancer and heart disorders are fueling adoption, and government initiatives to improve healthcare infrastructure support demand for molecular imaging.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market